Survival after laser surgery for twin-to-twin transfusion syndrome: when are they out of the woods?



      Severe, progressive twin-to-twin transfusion syndrome (TTTS) is associated with near-100% mortality if left untreated. Endoscopic laser ablation of placental vessels (ELA) is associated with 75% to 80% survival of at least one twin. The actuarial risk of fetal demise after ELA has not yet been described.

      Study Design

      A retrospective cohort study from 2 centers on a consecutive series of 163 sets of monochorionic twins with severe TTTS (18 Quintero stage I, 55 stage II, 71 stage III, 19 stage IV) who underwent ELA. Actuarial survival was calculated and stratified for donor vs recipient and according to stage.


      Median gestational age at diagnosis was 20.1 weeks; median operative time was 60 minutes. Overall survival was 63%, and survival of at least one twin was seen in 76% of pregnancies. Of fetal demises, 10% occurred within 48 hours after ELA, and 90% of all fetal demises occurred within 1 month. There was a 10% survival advantage of recipients over donors. Survival was similar for stages I, II, and IV (75%-80%), compared with 55% for stage III.


      Actuarial survival curves for TTTS confirms a greater burden on donor than on recipient but not at a previously reported 2:1 ratio. The current staging system does not accurately reflect post-ELA mortality risk. The unexpected higher mortality in stage III may reflect a more acute progression of the disorder in this group, an adverse effect of LA on an as yet unknown subgroup with stage III or, alternatively, preoperative demise of fulminant stage IV patients, leaving a stage IV subgroup with a more benign course and better outcome.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jain V.
        • Fisk N.M.
        The twin-twin transfusion syndrome.
        Clin Obstet Gynecol. 2004; 47: 181-202
        • Luks F.I.
        • Carr S.R.
        • De Paepe M.E.
        • et al.
        What- and why- the pediatric surgeon should know about twin-to-twin transfusion syndrome.
        J Pediatr Surg. 2005; 40: 1063-1069
        • Crombleholme T.M.
        The treatment of twin-twin transfusion syndrome.
        Semin Pediatr Surg. 2003; 12: 175-181
        • Kateb A.E.
        • Ville Y.
        Update on twin-to-twin transfusion syndrome.
        Best Pract Res Clin Obstet Gynaecol. 2008; 22: 63-75
        • Senat M.V.
        • Deprest J.
        • Boulvain M.
        • et al.
        A randomized trial of endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome at midgestation.
        N Engl J Med. 2004; 351: 136-144
        • Hecher K.
        • Plath H.
        • Bregenzer T.
        • et al.
        Endoscopic laser versus serial amniocenteses in the treatment of severe twin-twin transfusion syndrome.
        Am J Obstet Gynecol. 1999; 180: 717-724
        • Mari G.
        • Roberts A.
        • Detti L.
        • et al.
        Perinatal morbidity and mortality rates in severe twin-twin transfusion syndrome: results of the International Amnioreduction Registry.
        Am J Obstet Gynecol. 2001; 185: 708-715
        • Quintero R.A.
        • Comas C.
        • Bornick P.W.
        • et al.
        Selective versus non-selective laser photocoagulation of placental vessels in twin-to-twin transfusion syndrome.
        Ultrasound Obstet Gynecol. 2000; 16: 230-236
        • Ville Y.
        • Hyett J.
        • Hecher K.
        • et al.
        Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome.
        N Engl J Med. 1995; 332: 224-227
        • Ballard Dwan J.
        • Carr S.R.
        • Tracy T.F.
        • et al.
        Restricting LASER to stage III/IV twin-to-twin transfusion syndrome does not worsen outcome.
        Am J Obstet Gynecol. 2005; 193: S105
        • Cavicchioni O.
        • Yamamoto M.
        • Robyr R.
        • et al.
        Intrauterine fetal demise following laser treatment in twin-to-twin transfusion syndrome.
        BJOG. 2006; 113: 590-594
        • Martinez J.M.
        • Bermudez C.
        • Becerra C.
        • et al.
        The role of Doppler studies in predicting individual intrauterine fetal demise after laser therapy for twin-to-twin transfusion syndrome.
        Ultrasound Obstet Gynecol. 2003; 22: 246-251
        • Zikulnig L.
        • Hecher K.
        • Bregenzer T.
        • et al.
        Prognostic factors in severe twin-to-twin transfusion syndrome treated by endoscopic laser surgery.
        Ultrasound Obstet Gynecol. 1999; 14: 380-387
        • Mahone P.R.
        • Sherer D.M.
        • Abramowicz J.S.
        Twin transfusion syndrome: rapid development of severe hydrops of the donor following selective fetocide of the recipient.
        Am J Obstet Gynecol. 1993; 169: 166-168
        • Taylor M.J.
        • Shalev E.
        • Tanawattanacharoen S.
        Ultrasound-guided umbilical cord occlusion using bipolar diathermy for stage III/IV twin-twin transfusion syndrome.
        Prenat Diag. 2002; 22: 70-76
        • Quintero R.A.
        • Morales W.J.
        • Allen M.H.
        • et al.
        Staging of twin-twin transfusion syndrome.
        J Perinatol. 1999; 19: 550-555